Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Yu, Chu‐Ling"'
Autor:
Chang, Yun‐Hsuan1,2,3,4 (AUTHOR) yh.chang.snoopy@gmail.com, Yu, Chu‐Ling5,6 (AUTHOR), Huang, Chih‐Chun7,8 (AUTHOR), Wang, Tzu‐Yun8 (AUTHOR), Dziobek, Isabel9 (AUTHOR), Lane, Hsien‐Yuan5,10,11 (AUTHOR)
Publikováno v:
Brain & Behavior. Jan2024, Vol. 14 Issue 1, p1-11. 11p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Liao, Wei-Ting, You, Huey-Ling, Chai, Chee-Yin, Lee, Chih-Hung, Lan, Cheng-Che E., Chang, Shun-Jen, Yu, Chu-Ling, Yu, Hsin-Su
Publikováno v:
In Journal of Dermatological Science February 2018 89(2):191-197
Publikováno v:
In Dermatologica Sinica June 2017 35(2):78-84
Publikováno v:
In Dermatologica Sinica March 2017 35(1):1-6
Autor:
Rajaraman, Preetha, Doody, Michele M, Yu, Chu Ling, Preston, Dale L, Miller, Jeremy S, Sigurdson, Alice J, Freedman, D Michal, Alexander, Bruce H, Little, Mark P, Miller, Donald L, Linet, Martha S
Publikováno v:
Occupational and Environmental Medicine, 2016 Jan 01. 73(1), 21-27.
Externí odkaz:
http://www.jstor.org/stable/43870172
Autor:
Yu, Chu-Ling, Falk, Roni T., Kimlin, Michael G., Rajaraman, Preetha, Sigurdson, Alice J., Horst, Ronald L., Cosentino, Louis M., Linet, Martha S., Freedman, D. Michal
Publikováno v:
Cancer Causes & Control, 2010 Apr 01. 21(4), 643-648.
Externí odkaz:
https://www.jstor.org/stable/40645610
Autor:
Kuo, Yau-Chang, Yu, Chu-Ling, Liu, Chen-Yu, Wang, Su-Fen, Pan, Pi-Chen, Wu, Ming-Tsang, Ho, Chi-Kung, Lo, Yu-Shing, Li, Yi, Christiani, David C.
Publikováno v:
Cancer Causes & Control, 2009 Feb 01. 20(1), 57-65.
Externí odkaz:
https://www.jstor.org/stable/40271976
Autor:
Ali, Robbie, Yu, Chu-ling, Wu, Ming-tsang, Ho, Chi-kung, Pan, Bi-jen, Smith, Thomas, Christiani, David C.
Publikováno v:
Journal of Occupational and Environmental Medicine, 2004 Sep 01. 46(9), 985-992.
Externí odkaz:
https://www.jstor.org/stable/44996677
Autor:
Turner, Stuart, Chia, Stephen, Kanakamedala, Hemanth, Hsu, Wei-Chun, Park, Jinhee, Chandiwana, David, Ridolfi, Antonia, Yu, Chu-Ling, Zarate, Juan Pablo, Rugo, Hope S
Publikováno v:
The oncologist, vol 26, iss 7
BackgroundThe BYLieve trial (NCT03056755) confirmed efficacy and safety of alpelisib with fulvestrant for hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2-), PIK3CA-mutated advanced breast cancer (ABC), after c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::36f2c26d3173edf0333adbd07f3a65a0
https://escholarship.org/uc/item/0571s1jz
https://escholarship.org/uc/item/0571s1jz
